Dermavant Sciences Growth, Revenue, Number of Employees and Funding

Overview

Location:
Phoenix, AZ USA
Total Funding:N/A
Industry:Biotech
Founded:2016
Lead Investor(s):NovaQuest Capital Management
Press

Industry Ranking

Growjo 10k Ranking

Employee Data

  • Dermavant Sciences has 49 Employees.
  • Dermavant Sciences grew their employee count by -2% last year.
  • Dermavant Sciences currently has 2 job openings.

What Is Dermavant Sciences?

A Passion for Science and a Commitment to Dermatology Dermavant Sciences is a specialty biopharmaceutical company developing innovative prescription therapies for dermatologic diseases. Dermavant has acquired promising compounds that address unmet therapeutic needs and has rapidly established a robust dermatology R&D pipeline. We are dedicated to realizing the full potential of biomedical research and to developing and commercializing novel first-in-class or best-in-class therapies that improve patients lives. The patient is at the heart of everything we do.

keywords:N/A

49

Number of Employees

N/A

Revenue (est)

2

Current Jobs

-2%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Statistics & Da...
$10.1M9120%
Sun Devil Athle...
N/A5310%
Dermavant Scien...
N/A49-2%

Dermavant Sciences News

09/03/2019 - Dermavant Sciences officially withdraws $100 million IPO

Dermavant Sciences, a Phase 3 biotech developing in-licensed therapies for dermatological diseases, officially withdrew its plans for an initial ...

06/05/2019 - Dermavant Sciences Announces First Patient Dosed in ...

Dermavant Sciences Announces First Patient Dosed in PSOARING, its Pivotal Phase 3 Clinical Program for Tapinarof for the Topical Treatment ...

03/27/2019 - Dermavant Sciences Announces Appointment of Cyril ...

Dermavant Sciences Announces Appointment of Cyril Allouche as Chief Financial Officer and Provides Recent Corporate Update ...

Dermavant Sciences Funding

DateAmountRoundLead InvestorsReference
2018-08-29$100.0MUndisclosedNovaQuest Capital ManagementArticle

Dermavant Sciences Executive Hires

DateNameTitleReference
2017-10-02Vince IppolitoPresident/cooArticle
2018-04-04David RubensteinChief Scientific OfficerArticle
2018-09-05Frank TortiExecutive ChairArticle
2018-11-16Todd ZavodnickCEOArticle
2019-01-03Philip BrownChief Medical OfficerArticle
2019-03-28Cyril AlloucheChief Financial Officer (Chief Financial Officer)Article